| 1 |
30032131 | The Anaphylatoxin C3a Receptor Expression on Human M2 Macrophages Is Down-Regulated by Stimulating the Histamine H4 Receptor and the IL-4 Receptor. | 2018 |
1 |
| 2 |
24493825 | Molecular and stimulus-response profiles illustrate heterogeneity between peripheral and cord blood-derived human mast cells. | 2014 Jun |
1 |
| 3 |
26120516 | Human heart as a shock organ in anaphylaxis. | 2014 |
1 |
| 4 |
22155625 | Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells. | 2012 Jan |
1 |
| 5 |
18039528 | The role of the complement anaphylatoxins in the recruitment of eosinophils. | 2007 Dec 20 |
1 |
| 6 |
12612546 | F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. | 2003 Apr |
1 |
| 7 |
9585825 | Novel approaches to immunotherapy: epitopes, determinants, activators, or modulators? | 1998 Jan-Feb |
1 |
| 8 |
8625964 | Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. | 1996 Apr |
1 |
| 9 |
7513741 | Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. | 1994 May |
5 |
| 10 |
7679650 | Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a. | 1993 Feb |
1 |
| 11 |
1282507 | Mast cell heterogeneity in man: unique functional properties of skin mast cells in response to a range of polycationic stimuli. | 1992 Nov-Dec |
1 |
| 12 |
1373170 | A mechanism of action for anaphylatoxin C3a stimulation of mast cells. | 1992 Apr 15 |
2 |
| 13 |
1375610 | The effect of human anaphylatoxins and neutrophils on histamine release from isolated human skin mast cells. | 1992 Jan |
1 |
| 14 |
1697689 | Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. | 1990 Sep |
2 |
| 15 |
3026724 | Anaphylatoxins: possible roles in disease. | 1986 |
1 |
| 16 |
2579381 | Cardiac dysfunction caused by purified human C3a anaphylatoxin. | 1985 Feb |
3 |
| 17 |
3871207 | Microvascular effects of anaphylatoxins C3a and C5a. | 1985 Feb |
1 |
| 18 |
6170591 | Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release. | 1981 |
2 |
| 19 |
7047077 | The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. | 1981 Sep |
1 |
| 20 |
7011615 | Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis. | 1980 Dec |
4 |
| 21 |
7350527 | Inability of the C3a anaphylatoxin to promote cellular lysis. | 1980 Jan 3 |
1 |
| 22 |
89118 | Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. | 1979 Sep |
1 |
| 23 |
109469 | Complement-dependent histaminase release from human granulocytes. | 1979 Jun |
1 |
| 24 |
48505 | Release of histamine from rat mast cells by the complement peptides C3a and C5a. | 1975 Jun |
1 |
| 25 |
803505 | Purification and partial characterization of human and porcine C3a anaphylatoxin. | 1975 Feb 25 |
1 |
| 26 |
4097977 | Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. | 1970 Nov |
1 |